2010
DOI: 10.1124/mol.110.065367
|View full text |Cite
|
Sign up to set email alerts
|

Mutagenesis of Nucleophilic Residues near the Orthosteric Binding Pocket of M1and M2Muscarinic receptors: Effect on the Binding of Nitrogen Mustard Analogs of Acetylcholine and McN-A-343

Abstract: Investigating how a test drug alters the reaction of a sitedirected electrophile with a receptor is a powerful method for determining whether the drug acts competitively or allosterically, provided that the binding site of the electrophile is known. In this study, therefore, we mutated nucleophilic residues near and within the orthosteric pockets of M 1 and M 2 muscarinic receptors to identify where acetylcholine mustard and 4-[(2-bromoethyl)methyl-amino]-2-butynyl-N-(3-chlorophenyl)carbamate (BR384) bind cova… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

1
18
0

Year Published

2012
2012
2020
2020

Publication Types

Select...
5
1

Relationship

1
5

Authors

Journals

citations
Cited by 9 publications
(19 citation statements)
references
References 21 publications
(30 reference statements)
1
18
0
Order By: Relevance
“…While this might suggest that BR384 does not alkylate D3.32, and hence, the orthosteric site of M 1 – M 4 receptors, we found that irreversible alkylation of M 1 and M 2 receptors was competitively antagonized by NMS and allosterically inhibited by the allosteric modulator, gallamine (6, 9). We observed the same for the M 2 D3.32N mutant (8), suggesting that BR384 can alkylate a residue in the orthosteric binding pocket of M 1 and M 2 receptors other than D3.32. Although the D3.32N mutation lacked an inhibitory effect on the rate constant for alkylation, it did reduce the affinity of the aziridinium ion to about one-twentieth that of wild type M 1 - M 3 receptors and to about one-fourth that of the wild type M 4 receptor.…”
Section: Discussionsupporting
confidence: 58%
See 3 more Smart Citations
“…While this might suggest that BR384 does not alkylate D3.32, and hence, the orthosteric site of M 1 – M 4 receptors, we found that irreversible alkylation of M 1 and M 2 receptors was competitively antagonized by NMS and allosterically inhibited by the allosteric modulator, gallamine (6, 9). We observed the same for the M 2 D3.32N mutant (8), suggesting that BR384 can alkylate a residue in the orthosteric binding pocket of M 1 and M 2 receptors other than D3.32. Although the D3.32N mutation lacked an inhibitory effect on the rate constant for alkylation, it did reduce the affinity of the aziridinium ion to about one-twentieth that of wild type M 1 - M 3 receptors and to about one-fourth that of the wild type M 4 receptor.…”
Section: Discussionsupporting
confidence: 58%
“…Human embryonic kidney (HEK) 293 cells were cultured as described previously (8) and transfected with plasmids encoding mutated muscarinic receptors using GeneJammer following the manufacturer's protocols. After transfection, the cells were incubated for 48 h and harvested for assays.…”
Section: Methodsmentioning
confidence: 99%
See 2 more Smart Citations
“…M 2 receptors has indirect role by inhibiting cyclic adenosine monophosphate mediated relaxation in the bladder body [18] , and it has also investigated the influence of two toxins from the black mamba Dendroaspis polylepis on the kinetics of [ 3 H]-Nmethylscopolamine binding to muscarinic acetylcholine receptors from rat cerebral cortex and it was revealed that these toxins, MTα and MTβ, interact with the receptors via kinetically distinct mechanisms [19] . Kimber studied the structure, pharmacology and physiological importance of…”
Section: Muscarinic Receptorsmentioning
confidence: 99%